Hand Enterprise Solutions Co., Ltd.’s HKEX IPO Application Lapses; Ranking No.1 Among Domestic Providers of Corporate IT Consulting & Digital Solutions in China

NewTimeSpace News: According to official HKEX website information, the Main Board IPO application of Youcare Pharmaceutical Group Co., Ltd., handed in on 29 December 2025, has lapsed recently as the six-month validity window stipulated by HKEX listing rules expired. CITIC Securities was appointed as the sole sponsor when the application was submitted.

Founded in 2001, Youcare Pharmaceutical is a biopharma firm engaged in the research, development, manufacturing and commercialization of drugs covering four core therapeutic platforms: oligonucleotides, mRNA vaccines, peptide medicines and innovative TCM preparations. Starting out as a maker of generic chemical drugs, the Company later expanded into TCM formulations and small-molecule innovative drugs. In recent years, it has built a pipeline of novel drug candidates based on emerging modalities including oligonucleotides, mRNA vaccines and peptides.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.